Dr. Fadem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin
Suite 1730
Houston, TX 77030Phone+1 713-795-5511
Summary
- Dr. Fadem is a practicing Houston nephrologist. He began practice in 1978 after completing a renal fellowship at The University of Texas Health Science Center in San Antonio. He is a graduate of the University of Oklahoma College of Medicine, and did his internal medicine residency at The University of Texas and MD Anderson Hospital in Houston. He is a Clinical Professor of Medicine at Baylor College of medicine. Formerly from Tulsa, Oklahoma, Dr. Fadem is married and has three children.
He is also a diplomate of the American Board of Quality Assurance and Utilization Review Physicians, and a member of the American Society of Nephrology, International Society of Nephrology, Renal Physicians Association, the American Association of Kidney Patients and The National Kidney Foundation.
He is active in quality management, credentialing and peer review for his dialysis centers. He is also active in several civic and religious organizations and is a past Chairman of the Medical Advisory Board of the National Kidney Foundation of Southeast Texas. He was a founding member, and first president of the Gulf Coast Kidney Society.
On a national level, he is former Vice-President of the Board of Directors, and current Co-Chairman of the Medical Advisory Board and a member of the Board of Directors of the American Association of Kidney Patients. He is on three national RPA committees, the Government Affairs Committee, the Clinical Practice Committee and the Health Finance Committee. He serves on the Board of Directors of the Renal Physicians Association. He remains active in the Forum of ESRD Networks, and was a member of the Clinical Performance Measures Committee. He serves on the Technical Expert Panel for Dialysis Facility Compare, and chaired a sub committee on the Fistula First Initiative Task Force. He has served on Technical Expert Panels for the National Quality Forum, the National Committee on Quality Assurance, CMS and the Federal Motor Carriers Safety Association.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Nephrology, 1976 - 1978
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1973 - 1976
- University of Oklahoma College of MedicineClass of 1973
Certifications & Licensure
- TX State Medical License 1974 - 2027
- OK State Medical License 1974 - 2025
- TX State Medical License 1976 - 2024
- FL State Medical License 2012 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Join now to see all
Clinical Trials
- Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2014 May 01
- Safety Study of the Aethlon Hemopurifier Start of enrollment: 2014 Dec 01
Publications & Presentations
PubMed
- 144 citationsSodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextranBeckie Michael, Daniel W. Coyne, Steven Fishbane, Vaughn W. Folkert, Robert I. Lynn
Kidney International. 2002-05-01 - 137 citationsEstablishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus WorkshopAllison Tong, Braden Manns, Brenda R. Hemmelgarn, David C. Wheeler, Nicole Evangelidis
American Journal of Kidney Diseases. 2017-01-01 - 62 citationsEffect of prostaglandin E administration in a nephrotoxic and a vasoconstrictor model of acute renal failureRichard H. Mauk, Ram V. Patak, Stephen Z. Fadem, Meyer D. Lifscitz, Jay H. Stein
Kidney International. 1977-08-01
Press Mentions
- Meet Me at the MeetingSeptember 19th, 2022
- Expert COVID-19 Content on Open Access as Delta SurgesSeptember 7th, 2021
- Kidney Advocates Earn President's Service Awards for COVID-19 EffortsNovember 9th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: